TRAPS and MS: two diseases or an MS mimic?
Sriram
Subramaniam
S
D001921:Brain / Q000276:immunology / Q000473:pathology / Q000503:physiopathology; D002985:Clinical Protocols / Q000592:standards; D003937:Diagnosis, Differential; D004660:Encephalitis / Q000235:genetics* / Q000276:immunology* / Q000503:physiopathology; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects; D007166:Immunosuppressive Agents / Q000009:adverse effects; D008279:Magnetic Resonance Imaging; D009103:Multiple Sclerosis / Q000235:genetics* / Q000276:immunology* / Q000503:physiopathology; D010507:Periodicity; D018124:Receptors, Tumor Necrosis Factor / Q000235:genetics* / Q000276:immunology*; D013577:Syndrome; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics / Q000276:immunology
D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept